^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    onvapegleukin alfa (TransCon IL-2 β/γ)

    i
    Associations
    News
    Trials
    Company:
    Ascendis
    Drug class:
    CD122 agonist, IL-2R agonist, IL-2Rγ agonist
    Related drugs:
    Associations
    News
    Trials